相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
1990
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- Greg Papa, the longtime 49ers radio voice, faces an uncertain broadcasting future after spending 78 days in the ICU following a bone marrow transplant for acute lymphoblastic leukemia. - Complications including collapsed lungs, pneumonia, blood clots, and possible permanent lung scarring nearly killed Papa, with doctors estimating a 95% mortality rate for what he endured. - Papa was diagnosed with leukemia in July 2025 while in France, with cancer found in his brain and spinal column; he achieved remission after chemotherapy before receiving a transplant from his sister. - Despite requiring supplemental oxygen and pulmonary rehabilitation, Papa remains determined: "I will not say I cannot do it."
- Leading hospitals across North America are actively engaged in clinical trials to find effective treatments for trigeminal neuralgia, a condition causing severe facial pain. - Institutions like the University of Minnesota, Toronto Western Hospital, UCSF Medical Center, Kaizen Brain Center, and the University of South Florida are conducting these trials. - These trials aim to improve patients' quality of life by exploring innovative approaches to managing this challenging neurological disorder. - Many of these institutions initiated their first investigations into trigeminal neuralgia in 2022, marking a significant push for new treatment strategies.
- Advanced Practice Providers (APPs) play a crucial role in managing multiple myeloma patients by coordinating care and managing treatment side effects. - APPs leverage their nursing experience and clinical training to offer a unique perspective, bridging the gap between bedside care and clinical decision-making. - APPs are increasingly involved in patient education, community outreach, and identifying candidates for clinical trials, expanding their role in myeloma care. - The integration of APPs enhances efficiency and streamlines patient care, particularly in academic medical centers offering advanced myeloma treatments.
